RxSight, Inc. (RXST) Free cash flow
- Free cash flow · 12 months (USD): Value $-27.16M; Formula and calculation Operating cash flow minus capital spending; distinct from the saved levered FCF quote figure. Period ending 2026-06-30..
- Price / free cash flow · 12 months: Value (m); Formula and calculation Market cap / trailing-year free cash flow; inverse of FCF yield before percent scaling. Period ending 2026-06-30..
- Free cash flow yield · 12 months: Value (m); Formula and calculation (Operating cash flow − capital spending) / current market cap. Period ending 2026-06-30..
- Free cash flow margin · 12 months: Value -22.44%; Formula and calculation (Operating cash flow − capital spending) / revenue. Period ending 2026-06-30..
Free cash flow
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Free cash flow · 12 months (USD) | $-27.16M | Operating cash flow minus capital spending; distinct from the saved levered FCF quote figure. Period ending 2026-06-30. $-22.73M − $4.43M ≈ $-27.16M |
| Price / free cash flow · 12 months | (m) | Market cap / trailing-year free cash flow; inverse of FCF yield before percent scaling. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
| Free cash flow yield · 12 months | (m) | (Operating cash flow − capital spending) / current market cap. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
| Free cash flow margin · 12 months | -22.44% | (Operating cash flow − capital spending) / revenue. Period ending 2026-06-30. $-27.16M ÷ $121.08M × 100 ≈ -22.44% |
| Free cash flow per share · 12 months | (m) | (Trailing-year operating cash flow − capital spending) / reported quarter-end common shares. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
| Operating cash flow · 12 months | $-22.73M | Cash generated by operating activities. Period ending 2026-06-30. |
| Operating cash flow / net income · 12 months | 2.84× | Operating cash flow / net income. Period ending 2026-06-30. $-22.73M ÷ $-8.01M ≈ 2.84× |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Operating cash flow | -22.73M USD | Net Cash Provided by (Used in) Operating Activities |
| Capital spending | 4.43M USD | Payments to Acquire Property, Plant, and Equipment |
| Market cap | (m) | |
| Free cash flow | -27.16M USD | Net Cash Provided by (Used in) Operating Activities · Payments to Acquire Property, Plant, and Equipment |
| Revenue | 121.08M USD | Revenue from Contract with Customer, Excluding Assessed Tax |
| Quarter-end shares | (m) | Common Stock, Shares, Outstanding |
| Net income | -8.01M USD | Net Income (Loss) Attributable to Parent |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Free cash flow | FCF per share | Operating cash flow | Capital spending (USD) | Market cap (USD) | Revenue (USD) | Quarter-end shares (shares) | Net income (USD) | Price / FCF | FCF yield | FCF margin | Cash conversion |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $-27.16M | (m) | $-22.73M | $4.43M | (m) | $121.08M | (m) | $-8.01M | (m) | (m) | -22.44% | 2.84× |
| 2026-03-31 | $-21.58M | (m) | $-17.57M | $4.01M | (m) | $127.48M | (m) | $-7.69M | (m) | (m) | -16.93% | 2.28× |
| 2025-12-31 | $-19.34M | (m) | $-15.51M | $3.83M | (m) | $134.48M | (m) | $-38.94M | (m) | (m) | -14.38% | 0.40× |
| 2025-09-30 | $-22.20M | (m) | $-18.66M | $3.54M | (m) | $142.09M | (m) | $-35.73M | (m) | (m) | -15.62% | 0.52× |
| 2025-06-30 | $-20.88M | (m) | $-16.82M | $4.06M | (m) | $147.06M | (m) | $-32.25M | (m) | (m) | -14.20% | 0.52× |
| 2025-03-31 | $-20.52M | (m) | $-16.47M | $4.05M | (m) | $148.31M | (m) | $-26.55M | (m) | (m) | -13.83% | 0.62× |
| 2024-12-31 | $-22.39M | (m) | $-16.95M | $5.44M | (m) | $139.93M | (m) | $-27.45M | (m) | (m) | -16.00% | 0.62× |
| 2024-09-30 | $-27.17M | (m) | $-20.99M | $6.18M | (m) | $128.29M | (m) | $-30.69M | (m) | (m) | -21.18% | 0.68× |
| 2024-06-30 | $-35.35M | (m) | $-29.62M | $5.73M | (m) | $115.18M | (m) | $-36.77M | (m) | (m) | -30.69% | 0.81× |
| 2024-03-31 | $-39.17M | (m) | $-33.14M | $6.03M | (m) | $101.10M | (m) | $-44.50M | (m) | (m) | -38.75% | 0.74× |
| 2023-12-31 | $-46.41M | (m) | $-41.59M | $4.81M | (m) | $89.08M | (m) | $-48.61M | (m) | (m) | -52.10% | 0.86× |
| 2023-09-30 | $-50.73M | (m) | $-47.15M | $3.58M | (m) | $76.58M | (m) | $-55.04M | (m) | (m) | -66.24% | 0.86× |
| 2023-06-30 | $-57.86M | (m) | $-54.35M | $3.51M | (m) | $67.00M | (m) | $-59.44M | (m) | (m) | -86.36% | 0.91× |
| 2023-03-31 | $-64.40M | (m) | $-61.63M | $2.77M | (m) | $57.55M | (m) | $-62.37M | (m) | (m) | -111.90% | 0.99× |
| 2022-12-31 | $-61.24M | (m) | $-58.85M | $2.39M | (m) | $49.01M | (m) | $-66.76M | (m) | (m) | -124.97% | 0.88× |
| 2022-09-30 | $-56.11M | (m) | $-53.72M | $2.40M | (m) | $41.34M | (m) | $-66.88M | (m) | (m) | -135.73% | 0.80× |
| 2022-06-30 | $-54.35M | (m) | $-52.28M | $2.07M | (m) | $34.51M | (m) | $-62.73M | (m) | (m) | -157.49% | 0.83× |
| 2022-03-31 | $-51.25M | (m) | $-49.44M | $1.81M | (m) | $28.05M | (m) | $-59.48M | (m) | (m) | -182.71% | 0.83× |
| 2021-12-31 | $-46.65M | (m) | $-44.71M | $1.94M | (m) | $22.59M | (m) | $-48.69M | (m) | (m) | -206.47% | 0.92× |
| 2021-09-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2021-06-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2021-03-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $37.27M | (m) | (m) | (m) | (m) |
| 2020-12-31 | $-37.74M | (m) | $-35.20M | $2.54M | (m) | $14.68M | (m) | $27.57M | (m) | (m) | -257.13% | -1.28× |
| 2020-09-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2020-06-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Innovative Eyewear Inc (LUCY) | United States | $0.008B | |
| STAAR SURGICAL CO (STAA) | United States | $0.957B | 362.70 |
| National Vision Holdings, Inc. (EYE) | United States | $1.297B | |
| Warby Parker Inc. (WRBY) | United States | $2.970B | |
| Bausch & Lomb Corp (BLCO) | Canada | $6.008B | -34.58 |
| COOPER COMPANIES, INC. (COO) | United States | $10.533B | 24.09 |